Images

Filter by

Relative Survival Rates of Patients Receiving Subcutaneous Treprostinil
Relative Survival Rates of Patients Receiving Subcutaneous Treprostinil
One-year Survival in the Validation Cohort Stratified According to Estimated Probability of Surviving One Year
One-year Survival in the Validation Cohort Stratified According to Estimated Probability of Surviving One Year
Baseline Predictors of Survival
Baseline Predictors of Survival
Goal-oriented Strategy Developed at the Pulmonary Hypertension Clinic at Erasme University
Goal-oriented Strategy Developed at the Pulmonary Hypertension Clinic at Erasme University
Kaplan–Meier Survival Estimates in 57 Patients with Precapillary Pulmonary Hypertension After Prostanoid Initiation
Kaplan–Meier Survival Estimates in 57 Patients with Precapillary Pulmonary Hypertension After Prostanoid Initiation
Suggested Treatment Algorithm for Pulmonary Arterial Hypertension
Suggested Treatment Algorithm for Pulmonary Arterial Hypertension
Parameters with Established Importance for Assessing Disease Severity, Stability and Prognosis in Pulmonary Arterial Hypertension
Parameters with Established Importance for Assessing Disease Severity, Stability and Prognosis in Pulmonary Arterial Hypertension
Clinical Trial Data Assessing Efficacy of Prostanoid Therapy
Clinical Trial Data Assessing Efficacy of Prostanoid Therapy
Functional Classification of Pulmonary Hypertension According to World Health Organization
Functional Classification of Pulmonary Hypertension According to World Health Organization
Presenting Symptoms of Pulmonary Arterial Hypertension
Presenting Symptoms of Pulmonary Arterial Hypertension
A Greater Reduction in Pulmonary Vascular Resistance (Dashed Line) may Reduce Pulmonary Artery Pressure and is Required to Reduce Right Ventricular Power. Such a Reduction may Potentially be Achievable by Upfront Combination Therapy (Purple Line = Pulmonary Artery Pressure; Red Line = Stroke Volume)
A Greater Reduction in Pulmonary Vascular Resistance (Dashed Line) may Reduce Pulmonary Artery Pressure and is Required to Reduce Right Ventricular Power. Such a Reduction may Potentially be Achievable by Upfront Combination Therapy (Purple Line = Pulmonary Artery Pressure; Red Line = Stroke Volume)
Mean Pulmonary Pressure (Purple Line) and Stroke Volume (Red Line) in Pulmonary Arterial Hypertension at Different Stages of Disease Severity, classified by New York Heart Association (NYHA) Class
Mean Pulmonary Pressure (Purple Line) and Stroke Volume (Red Line) in Pulmonary Arterial Hypertension at Different Stages of Disease Severity, classified by New York Heart Association (NYHA) Class